Clinical Trial Update: The Effect of Guanfacine on Delirium in Critically Ill Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating guanfacine for delirium in critically ill patients has completed, with results posted in 2024-04-17. The sponsor is the University of A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Delirium | Phase 3 | Status: COMPLETED | Results posted: 2024-04-17